Table 1 Comparison of baseline clinical and laboratory characteristics between CTX and CYA groups
Characteristics | CTX group (n = 23) | CYA group (n = 24) | P value |
|---|---|---|---|
Men, n (%) | 16 (69.6) | 13 (54.2) | 0.28 |
Age (yrs), mean ± SD | 43 ± 12 | 42 ± 15 | 0.72 |
Body mass index (kg/m2), M (P25, P75) | 25 (23, 29) | 25 (23, 27) | 0.87 |
Serum albumin (g/L), mean ± SD | 26.1 ± 5.3 | 28.0 ± 5.8 | 0.25 |
24hUP (g/d), M (P25, P75) | 8.28 (3.63, 10.98) | 4.73 (3.38, 8.60) | 0.14 |
Nephrotic syndrome, n (%) | 14 (60.9) | 16 (66.7) | 0.68 |
Scr (μmol/L), mean ± SD | 78.7 ± 24.7 | 71.3 ± 19.0 | 0.26 |
eGFR (mL/min per 1.73m2), mean ± SD | 103 ± 28 | 115 ± 24 | 0.15 |
Lymphocyte count (×109/L), mean ± SD | 2.51 ± 1.04 | 2.25 ± 0.81 | 0.32 |
Anti-PLA2R antibody titer (RU/ml), M (P25, P75) | 66.4 (31.5, 192.4) | 63.4 (33.6, 174.0) | 0.69 |
Systolic pressure (mmHg), mean ± SD | 127 ± 8 | 127 ± 14 | 0.995 |
Diastolic pressure (mmHg), mean ± SD | 77 ± 11 | 78 ± 10 | 0.75 |